IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS - ANVISA Registration 80000230072

Access comprehensive regulatory information for IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 80000230072 and manufactured by AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD., ABBOTT MOLECULAR, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.